From The Washington Times.com (Sept. 23):
Pharmaceutical giant Johnson & Johnson started a massive human trial of its coronavirus vaccine Wednesday, lining up another option as federal officials told Congress they will resist political pressure ahead of an unprecedented push to inoculate the country.
The Janssen Pharmaceutical Companies of J&J said it plans to enroll up to 60,000 adults at nearly 215 clinical research sites in the U.S. and abroad. The company said its vaccine candidate offers twin advantages over some of its competitors — it can be delivered in a single dose and doesn’t require unusually cold storage temperatures.
The Trump administration, through “Operation Warp Speed,” is supporting private drugmakers as it tries to lock down a successful vaccine before the end of the year. [read more]
Posts
No comments:
Post a Comment